CanSino Biologics Inc. (HKG:6185)

CanSino Biologics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,182	11,610	12,514	27,690	66,111	74,412
Market Cap Growth	16.76%	-7.23%	-54.81%	-58.12%	-11.15%	466.94%
Enterprise Value	11,689	10,302	10,611	23,868	58,920	68,404
Last Close Price	35.40	31.50	23.55	66.75	177.89	174.24
PE Ratio	-	-	-	-	28.13	-
Forward PE	45.58	-	-	-	11.16	25.30
PS Ratio	12.41	12.89	31.81	23.68	12.53	2517.38
PB Ratio	2.45	2.22	2.15	3.38	6.30	10.32
P/TBV Ratio	2.55	2.28	2.21	3.75	6.89	10.38
P/FCF Ratio	-	-	-	-	63.60	-
P/OCF Ratio	78.51	-	-	-	26.27	-
EV/Sales Ratio	11.01	11.44	26.97	20.41	11.16	2314.14
EV/EBITDA Ratio	-	-	-	-	25.96	-
EV/EBIT Ratio	-	-	-	-	26.91	-
EV/FCF Ratio	-68.29	-	-	-	56.68	-
Debt / Equity Ratio	0.29	0.41	0.51	0.37	0.16	0.02
Debt / EBITDA Ratio	-	-	-	-	0.74	-
Debt / FCF Ratio	-	-	-	-	1.62	-
Asset Turnover	0.13	0.10	0.03	0.09	0.46	0.01
Inventory Turnover	0.71	0.83	1.55	1.57	2.48	0.16
Quick Ratio	3.24	2.38	1.86	2.33	2.78	12.54
Current Ratio	3.62	2.54	2.02	2.64	3.25	13.24
Return on Equity (ROE)	-2.84%	-7.52%	-31.40%	-12.22%	26.09%	-10.52%
Return on Assets (ROA)	-1.87%	-2.74%	-10.36%	-8.03%	11.97%	-7.58%
Return on Invested Capital (ROIC)	-2.11%	-3.18%	-12.01%	-9.43%	13.82%	-8.24%
Return on Capital Employed (ROCE)	-3.70%	-6.00%	-25.50%	-17.50%	19.80%	-8.20%
Earnings Yield	-1.18%	-3.47%	-13.05%	-3.71%	3.55%	-0.63%
FCF Yield	-1.30%	-5.73%	-13.37%	-11.95%	1.57%	-1.02%
Dividend Yield	-	-	-	-	0.55%	-
Payout Ratio	-	-	-	-	0.74%	-
Buyback Yield / Dilution	1.66%	-0.38%	0.17%	0.08%	-7.26%	-13.46%
Total Shareholder Return	1.66%	-0.38%	0.17%	0.08%	-6.70%	-13.46%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.